revenues. More on Press Releases Market Activity Covidien Ltd.| COV "We believe Covidien has improved its top-line growth prospects through portfolio optimization," said Phillip Seligman, Healthcare Analyst at Standard & Poor's Equity Research. "Since...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to S&P Equity Research Picks COV Focus Stock Of The Week
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account